Beijing Aosaikang Pharmaceutical Co., Ltd. (SHE:002755)

China · Delayed Price · Currency is CNY

17.74

+1.61 (9.98%)

May 20, 2026, 11:54 AM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Anti-infection	399.47M	493.92M	282.34M	162.25M	-
Anti-infection Growth	-19.12%	74.94%	74.01%	-	-
Anti-Tumor	710.57M	631.18M	616.95M	651.41M	799.71M
Anti-Tumor Growth	12.58%	2.31%	-5.29%	-18.54%	-3.55%
Chronic Diseases	395.28M	323.39M	205.14M	145.74M	-
Chronic Diseases Growth	22.23%	57.65%	40.75%	-	-
Digestive	218.93M	269.90M	299.01M	856.01M	1.91B
Digestive Growth	-18.89%	-9.74%	-65.07%	-55.09%	-25.73%
Other Category	10.84M	22.20M	26.25M	43.55M	335.70M
Other Category Growth	-51.17%	-15.43%	-39.73%	-87.03%	3.62%
Unallocated Other Operations	43.93M	37.05M	13.77M	13.61M	65.22M
Unallocated Other Operations Growth	18.57%	169.04%	1.19%	-79.13%	2.91%
Total	1.78B	1.78B	1.44B	1.87B	3.11B
Total Growth	0.08%	23.15%	-22.92%	-39.72%	-17.87%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	1.78B	1.78B	1.44B	1.87B	3.11B
China Growth	0.08%	23.15%	-22.92%	-39.72%	-17.87%
Total	1.78B	1.78B	1.44B	1.87B	3.11B
Total Growth	0.08%	23.15%	-22.92%	-39.72%	-17.87%

Source: S&P Global Market Intelligence.